SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-22-007103
Filing Date
2022-11-04
Accepted
2022-11-04 08:00:16
Documents
17
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_110322.htm 6-K 10659
2 EXHIBIT 99.1 exh_991.htm EX-99.1 253886
3 EXHIBIT 99.2 exh_992.htm EX-99.2 216011
4 EXHIBIT 99.3 exh_993.htm EX-99.3 5475
5 EXHIBIT 99.4 exh_994.htm EX-99.4 5449
6 EXHIBIT 99.5 exh_995.htm EX-99.5 17427
7 GRAPHIC cellactivation.jpg GRAPHIC 215711
8 GRAPHIC doses.jpg GRAPHIC 169048
9 GRAPHIC eosinophilia.jpg GRAPHIC 190708
10 GRAPHIC expandedcells.jpg GRAPHIC 206699
11 GRAPHIC logo.jpg GRAPHIC 13084
12 GRAPHIC lymphocyte.jpg GRAPHIC 192492
13 GRAPHIC mdna11.jpg GRAPHIC 249172
14 GRAPHIC mdna223.jpg GRAPHIC 55842
15 GRAPHIC overview.jpg GRAPHIC 198034
16 GRAPHIC proliferation.jpg GRAPHIC 151630
17 GRAPHIC summary.jpg GRAPHIC 277293
  Complete submission text file 0001171843-22-007103.txt   3148935
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 221360218
SIC: 2834 Pharmaceutical Preparations